Tongue orthotopic xenografts to study fusion-negative rhabdomyosarcoma invasion and metastasis in live animals
Cell Reports Methods · 2024
DOI: 10.1016/j.crmeth.2024.100802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports Methods, 2024. Verfasst von Sarah M Hammoudeh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Rhabdomyosarcoma, Neoplasm Invasiveness, Tongue Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS, U.S. Department of Health and Human Services, National Institutes of Health.
Abstract (Originalsprache)
PAX3/7 fusion-negative rhabdomyosarcoma (FN-RMS) is a childhood mesodermal lineage malignancy with a poor prognosis for metastatic or relapsed cases. Limited understanding of advanced FN-RMS is partially attributed to the absence of sequential invasion and dissemination events and the challenge in studying cell behavior, using, for example, non-invasive intravital microscopy (IVM), in currently used xenograft models. Here, we developed an orthotopic tongue xenograft model of FN-RMS to study cell behavior and the molecular basis of invasion and metastasis using IVM. FN-RMS cells are retained in the tongue and invade locally into muscle mysial spaces and vascular lumen, with evidence of hematogenous dissemination to the lungs and lymphatic dissemination to lymph nodes. Using IVM of tongue xenografts reveals shifts in cellular phenotype, migration to blood and lymphatic vessels, and lymphatic intravasation. Insight from this model into tumor invasion and metastasis at the tissue, cellular, and subcellular level can guide new therapeutic avenues for advanced FN-RMS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
- Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA; CCR-Intravital Microscopy Core, Center for Cancer Research, National Cancer Institute, Bethesda, MD…
- Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
- Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA; Copenhagen Center for Glycomics, University of Copenhagen, Department for Cellular and Molecular Me…
- Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. Electronic address: randazzp@mail.nih.gov.
Förderung
- Intramural NIH HHS
- U.S. Department of Health and Human Services
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Hammoudeh, S. M., Ng, Y., Wei, B. R., Madsen, T. D., Yadav, M. P., Simpson, R. M., Weigert, R., & Randazzo, P. A. (2024). Tongue orthotopic xenografts to study fusion-negative rhabdomyosarcoma invasion and metastasis in live animals. Cell Reports Methods. https://doi.org/10.1016/j.crmeth.2024.100802
Vancouver
Hammoudeh SM, Ng Y, Wei BR, Madsen TD, Yadav MP, Simpson RM, et al. Tongue orthotopic xenografts to study fusion-negative rhabdomyosarcoma invasion and metastasis in live animals. Cell Reports Methods. 2024. doi:10.1016/j.crmeth.2024.100802
BibTeX
@article{Hammoudeh2024,
author = {Hammoudeh, Sarah M and Ng, Yeap and Wei, Bih-Rong and Madsen, Thomas D and Yadav, Mukesh P and Simpson, R Mark and Weigert, Roberto and Randazzo, Paul A},
title = {Tongue orthotopic xenografts to study fusion-negative rhabdomyosarcoma invasion and metastasis in live animals},
journal = {Cell Reports Methods},
year = {2024},
doi = {10.1016/j.crmeth.2024.100802}
}
EUVIMED